116 related articles for article (PubMed ID: 10874308)
1. Signature-based analysis of MET proto-oncogene mutations using DHPLC.
Nickerson ML; Weirich G; Zbar B; Schmidt LS
Hum Mutat; 2000; 16(1):68-76. PubMed ID: 10874308
[TBL] [Abstract][Full Text] [Related]
2. Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods.
Nickerson ML; Warren MB; Zbar B; Schmidt LS
Hum Mutat; 2001 Mar; 17(3):210-9. PubMed ID: 11241843
[TBL] [Abstract][Full Text] [Related]
3. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients.
Salvi A; Marchina E; Benetti A; Grigolato P; De Petro G; Barlati S
Int J Oncol; 2008 Aug; 33(2):271-6. PubMed ID: 18636147
[TBL] [Abstract][Full Text] [Related]
4. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
5. Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.
Yu B; Sawyer NA; Caramins M; Yuan ZG; Saunderson RB; Pamphlett R; Richmond DR; Jeremy RW; Trent RJ
J Clin Pathol; 2005 May; 58(5):479-85. PubMed ID: 15858117
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC.
Su YN; Lee CN; Hung CC; Chen CA; Cheng WF; Tsao PN; Yu CL; Hsieh FJ
Hum Mutat; 2003 Oct; 22(4):326-36. PubMed ID: 12955718
[TBL] [Abstract][Full Text] [Related]
8. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
Greiner TC
Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
10. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
Andrulis IL; Anton-Culver H; Beck J; Bove B; Boyd J; Buys S; Godwin AK; Hopper JL; Li F; Neuhausen SL; Ozcelik H; Peel D; Santella RM; Southey MC; van Orsouw NJ; Venter DJ; Vijg J; Whittemore AS;
Hum Mutat; 2002 Jul; 20(1):65-73. PubMed ID: 12112659
[TBL] [Abstract][Full Text] [Related]
11. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
Shabbeer J; Robinson M; Desnick RJ
Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
[TBL] [Abstract][Full Text] [Related]
12. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.
Chou LS; Lyon E; Wittwer CT
Am J Clin Pathol; 2005 Sep; 124(3):330-8. PubMed ID: 16191501
[TBL] [Abstract][Full Text] [Related]
13. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
14. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis.
Bénit P; Bonnefont JP; Kara Mostefa A; Francannet C; Munnich A; Ray PF
Prenat Diagn; 2001 Apr; 21(4):279-83. PubMed ID: 11288117
[TBL] [Abstract][Full Text] [Related]
15. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.
Schmidt L; Junker K; Weirich G; Glenn G; Choyke P; Lubensky I; Zhuang Z; Jeffers M; Vande Woude G; Neumann H; Walther M; Linehan WM; Zbar B
Cancer Res; 1998 Apr; 58(8):1719-22. PubMed ID: 9563489
[TBL] [Abstract][Full Text] [Related]
16. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
18. Rapid genotyping of known mutations and polymorphisms in beta-globin gene based on the DHPLC profile patterns of homoduplexes and heteroduplexes.
Li Q; Li LY; Huang SW; Li L; Chen XW; Zhou WJ; Xu XM
Clin Biochem; 2008 Jun; 41(9):681-7. PubMed ID: 18339318
[TBL] [Abstract][Full Text] [Related]
19. [Temperature-modulated high-performance liquid chromatography for detecting variation in human genome].
Hou Y; Zhang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):145-8. PubMed ID: 10837511
[TBL] [Abstract][Full Text] [Related]
20. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography.
Biggin A; Henke R; Bennetts B; Thorburn DR; Christodoulou J
Mol Genet Metab; 2005 Jan; 84(1):61-74. PubMed ID: 15639196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
